Ftse Mib
36.429,72
0,16%
DAX
21.727,20
0,48%
S&P 500
6.071,17
0,53%
NASDAQ
19.681,75
0,25%
Bitcoin
104.168,25
-0,54%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Perspective Therapeutics Inc (CATX) Perspective Therapeutics Inc (CATX) Notizie

CATX

Perspective Therapeutics (CATX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:CATX
DataOraFonteTitoloSimboloCompagnia
24/01/202513:26Edgar (US Regulatory)Form 8-K - Current reportAMEX:CATXPerspective Therapeutics Inc
24/01/202513:00GlobeNewswire Inc.Perspective Therapeutics Continues to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Updated Interim Data Presented at the 2025 ASCO Gastrointestinal Cancers SymposiumAMEX:CATXPerspective Therapeutics Inc
22/01/202513:00GlobeNewswire Inc.Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET to be Presented at the ASCO Gastrointestinal Cancers Symposium on January 24, 2025AMEX:CATXPerspective Therapeutics Inc
13/01/202514:00GlobeNewswire Inc.Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 43rd Annual J.P. Morgan Healthcare ConferenceAMEX:CATXPerspective Therapeutics Inc
10/01/202513:00GlobeNewswire Inc.Perspective Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceAMEX:CATXPerspective Therapeutics Inc
07/01/202522:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CATXPerspective Therapeutics Inc
07/01/202522:48Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:CATXPerspective Therapeutics Inc
06/01/202514:00GlobeNewswire Inc.Perspective Therapeutics Appoints Juan Graham, MBA as Chief Financial OfficerAMEX:CATXPerspective Therapeutics Inc
04/12/202423:17Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]AMEX:CATXPerspective Therapeutics Inc
27/11/202413:00GlobeNewswire Inc.Perspective Therapeutics to Participate in Upcoming Investor Conferences in DecemberAMEX:CATXPerspective Therapeutics Inc
21/11/202413:15GlobeNewswire Inc.Perspective Therapeutics to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Data Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical SymposiumAMEX:CATXPerspective Therapeutics Inc
15/11/202422:08GlobeNewswire Inc.Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024AMEX:CATXPerspective Therapeutics Inc
15/11/202400:14Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:CATXPerspective Therapeutics Inc
14/11/202422:05Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]AMEX:CATXPerspective Therapeutics Inc
12/11/202422:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:CATXPerspective Therapeutics Inc
12/11/202422:05GlobeNewswire Inc.Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 3Q 2024 ResultsAMEX:CATXPerspective Therapeutics Inc
31/10/202412:00GlobeNewswire Inc.Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2024 Financial ResultsAMEX:CATXPerspective Therapeutics Inc
29/10/202412:00GlobeNewswire Inc.Perspective Therapeutics to Participate in Upcoming Investor Conferences in NovemberAMEX:CATXPerspective Therapeutics Inc
23/10/202413:00GlobeNewswire Inc.Perspective Therapeutics Presents Updates at the 37th Annual Congress of the European Association of Nuclear MedicineAMEX:CATXPerspective Therapeutics Inc
16/10/202413:00GlobeNewswire Inc.Perspective Therapeutics Begins Shipping Investigational Products from State-of-the-Art Radiopharmaceutical Manufacturing Facility in Somerset, New JerseyAMEX:CATXPerspective Therapeutics Inc
11/10/202414:30GlobeNewswire Inc.Perspective Therapeutics to Advance Investigation of Potential First-In-Class Radiopharmaceutical Therapy [212Pb]VMT01 Based on Data Presented at the 21st International Congress of the Society for Melanoma ResearchAMEX:CATXPerspective Therapeutics Inc
10/10/202423:14GlobeNewswire Inc.Perspective Therapeutics to Present at the 21st International Congress of the Society for Melanoma ResearchAMEX:CATXPerspective Therapeutics Inc
07/10/202413:00GlobeNewswire Inc.Perspective Therapeutics to Participate at the Oppenheimer Targeted Radiopharmaceutical Therapies in Oncology Summit & JonesResearch Virtual Radiopharma DayAMEX:CATXPerspective Therapeutics Inc
30/09/202413:00GlobeNewswire Inc.Perspective Therapeutics to Present at the 37th Annual Congress of the European Association of Nuclear MedicineAMEX:CATXPerspective Therapeutics Inc
10/09/202413:00GlobeNewswire Inc.Perspective Therapeutics Presents at the World Molecular Imaging Congress 2024AMEX:CATXPerspective Therapeutics Inc
05/09/202413:00GlobeNewswire Inc.Perspective Therapeutics Granted Fast Track Designation for VMT01 for the Diagnosis and Treatment of MC1R-Positive MelanomaAMEX:CATXPerspective Therapeutics Inc
28/08/202413:00GlobeNewswire Inc.Perspective Therapeutics to Participate in Upcoming Investor Conferences in SeptemberAMEX:CATXPerspective Therapeutics Inc
13/08/202411:39IH Market NewsRumble Shares Up 7% in Premarket After 27% Q2 Revenue Surge; More on EarningsAMEX:CATXPerspective Therapeutics Inc
12/08/202422:05GlobeNewswire Inc.Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 2Q 2024 ResultsAMEX:CATXPerspective Therapeutics Inc
12/08/202411:47IH Market NewsU.S. Futures Steady as Markets Await Key Inflation Data, Oil Prices ClimbAMEX:CATXPerspective Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:CATX

La tua Cronologia

BIT
STMMI
ST Microelectronics
BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
ENAV
Enav
BIT
ENEL
Enel
BIT
RACE
Ferrari NV
BIT
IVG
Iveco Group NV
BIT
PRY
Prysmian
BIT
ENI
Eni
BIT
G
Generali
BIT
CPR
Davide Campari
BIT
TIT
Telecom Italia
BIT
BPE
Bper Banca
BIT
LDO
Leonardo
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci